Upexi Inc specializes in the development, manufacturing, and distribution of consumer products with diversification into the cryptocurrency space via Solana... Show more
Upexi, Inc. (Nasdaq: UPXI) is a Tampa, Florida-based company that has repositioned itself from a diversified consumer-brands owner into a Solana-focused digital-asset treasury company. Formerly known as Grove, Inc., the company changed its name in August 2022 and historically operated brands including LuckyTail, PRAX, Cure Mushrooms, Moonwlkr, and Gumi Labs across health, wellness, pet, and beauty categories.
In early 2026, Upexi shifted its core strategy to acquiring and holding Solana (SOL) in what management describes as a "disciplined and accretive" manner. The company now holds more than two million SOL and pursues value creation through three mechanisms: intelligent capital issuance, staking rewards, and discounted purchases of locked SOL tokens. While the legacy consumer products business is being wound down, the treasury operation has become the primary driver of the stock's valuation and its day-to-day price action.
Over the last 30 days, UPXI advanced approximately 36%, rising from a closing price of $0.79 on July 29 to $1.08 at the latest close. The move was back-loaded, with the bulk of the gains arriving in the second half of August as trading volume expanded sharply alongside renewed interest in the company's Solana treasury position.
The picture over the trailing quarter is more mixed. Three months earlier, shares traded near $1.21 in late May, meaning the stock is still down roughly 11% on a quarter-over-quarter basis despite the recent surge. The quarterly path was marked by considerable volatility: shares declined through June and early August to a low near $0.75 before staging a rapid recovery. This divergence underscores how quickly sentiment around the company's crypto-linked balance sheet can shift.
The 30-day advance was driven primarily by Upexi's Solana treasury narrative rather than its legacy consumer operations. Several verified developments contributed to the move:
The broader three-month trend reflects the inherent volatility of a small-cap equity increasingly tied to a single digital asset. Early in the quarter, the company reported fiscal third-quarter results showing total revenue of about $4.6 million, including roughly $3.5 million in digital-asset revenue, while the legacy consumer segment continued to shrink. The company also pursued multiple capital raises, including a private placement and a resale registration for millions of shares, which introduced dilution concerns that weighed on the stock through June and July.
Solana's own price fluctuations compounded the swings, with the stock's mid-August trough near $0.75 giving way to the current rebound as crypto sentiment improved and Upexi's accumulation strategy regained investor attention. The result is a quarter defined by a steep drawdown followed by an equally sharp recovery, leaving the stock modestly lower over three months despite the strong 30-day gain.
Tickeron's Trending AI Robots page showcases a curated selection of AI-powered trading bots designed to analyze markets and execute trades across a wide universe of tickers. While Tickeron offers hundreds of AI trading bots covering thousands of securities, only the top-performing and most relevant bots are featured in this section. These bots vary by trading strategy, timeframe, and performance metrics, giving traders a range of approaches to explore. For investors following volatile, news-driven names such as Upexi, AI-driven tools can offer an additional layer of signal and structure. Those interested can visit the Trending AI Robots page to review the currently featured bots and their performance profiles.
Investors monitoring Upexi should focus on several forward-looking factors. The company's fiscal results, scheduled for release in late September, will provide an updated view of digital-asset revenue, staking income, and the progress of the consumer-business wind-down. The price of Solana remains the single largest driver of the stock, so token-market conditions and staking yields will continue to shape both the balance sheet and investor sentiment.
Capital structure is another key consideration. Continued reliance on equity and convertible-note issuance can dilute existing shareholders, while the pace of treasury accumulation and the ratio of the company's market value to its SOL holdings remain closely watched metrics. Finally, the broader regulatory environment for digital assets — including developments around Solana-related investment products — and overall crypto market sentiment are likely to influence the stock's trajectory. These factors present both opportunity and meaningful risk, and they warrant careful monitoring rather than any presumption about future performance.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The 10-day RSI Oscillator for UPXI moved out of overbought territory on August 28, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 17 instances where the indicator moved out of the overbought zone. In 17 of the 17 cases the stock moved lower in the days that followed. This puts the odds of a move down at 90%.
The Momentum Indicator moved below the 0 level on September 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on UPXI as a result. In 91 of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for UPXI turned negative on September 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 37 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where UPXI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
UPXI broke above its upper Bollinger Band on August 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for UPXI entered a downward trend on August 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
UPXI moved above its 50-day moving average on August 19, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for UPXI crossed bullishly above the 50-day moving average on August 24, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
Following a +22.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where UPXI advanced for three days, in 204 of 237 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
The Tickeron Valuation Rating of 33 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.853) is normal, around the industry mean (5.849). P/E Ratio (1.953) is within average values for comparable stocks, (27.560). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (27.634). Dividend Yield (0.000) settles around the average of (0.048) among similar stocks. P/S Ratio (2.077) is also within normal values, averaging (69.923).
The Tickeron Price Growth Rating for this company is 54 (best 1 - 100 worst), indicating steady price growth. UPXI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. UPXI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry InternetSoftwareServices